A multi-institutional study of short-term mortality in COVID-positive patients undergoing hip fracture surgery: is survival better than expected?
- PMID: 37462783
- DOI: 10.1007/s00590-023-03620-z
A multi-institutional study of short-term mortality in COVID-positive patients undergoing hip fracture surgery: is survival better than expected?
Abstract
Purpose: Early reports of 30-day mortality in COVID-positive patients with hip fracture were often over 30% and were higher than historical rates of 10% in pre-COVID studies. We conducted a multi-institutional retrospective cohort study to determine whether the incidence of 30-day mortality and complications in COVID-positive patients undergoing hip fracture surgery is as high as initially reported.
Methods: A retrospective chart review was performed at 11 level I trauma centers from January 1, 2020 to May 1, 2022. Patients 50 years or older undergoing hip fracture surgery with a positive COVID test at the time of surgery were included. The primary outcome measurements were the incidence of 30-day mortality and complications. Post-operative outcomes were reported using proportions with 95% confidence interval (C.I.).
Results: Forty patients with a median age of 71.5 years (interquartile range, 50-87 years) met the criteria. Within 30-days, four patients (10%; 95% C.I. 3-24%) died, four developed pneumonia, three developed thromboembolism, and three remained intubated post-operatively. Increased age was a statistically significant predictor of 30-day mortality (p = 0.01), with all deaths occurring in patients over 80 years.
Conclusion: In this multi-institutional analysis of COVID-positive patients undergoing hip fracture surgery, 30-day mortality was 10%. The 95% C.I. did not include 30%, suggesting that survival may be better than initially reported. While COVID-positive patients with hip fractures have high short-term mortality, the clinical situation may not be as dire as initially described, which may reflect initial publication bias, selection bias introduced by testing, or other issues.
Levels of evidence: Therapeutic Level III.
Keywords: 30-day mortality; COVID;; Complications; Hip fracture surgery; Short-term mortality.
© 2023. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.
Similar articles
-
IMPACT-Scot report on COVID-19 and hip fractures.Bone Joint J. 2020 Sep;102-B(9):1219-1228. doi: 10.1302/0301-620X.102B9.BJJ-2020-1100.R1. Epub 2020 Jul 7. Bone Joint J. 2020. PMID: 32634029
-
The effects of COVID-19 on perioperative morbidity and mortality in patients with hip fractures.Bone Joint J. 2020 Sep;102-B(9):1136-1145. doi: 10.1302/0301-620X.102B9.BJJ-2020-1127.R1. Epub 2020 Jul 7. Bone Joint J. 2020. PMID: 32634023
-
Increased Mortality and Major Complications in Hip Fracture Care During the COVID-19 Pandemic: A New York City Perspective.J Orthop Trauma. 2020 Aug;34(8):395-402. doi: 10.1097/BOT.0000000000001845. J Orthop Trauma. 2020. PMID: 32482976 Free PMC article.
-
Postoperative mortality in the COVID-positive hip fracture patient, a systematic review and meta-analysis.Eur J Orthop Surg Traumatol. 2023 May;33(4):927-935. doi: 10.1007/s00590-022-03228-9. Epub 2022 Feb 23. Eur J Orthop Surg Traumatol. 2023. PMID: 35195751 Free PMC article.
-
Meta-analysis and metaregression of risk factors associated with mortality in hip fracture patients during the COVID-19 pandemic.Sci Rep. 2021 May 12;11(1):10157. doi: 10.1038/s41598-021-89617-2. Sci Rep. 2021. PMID: 33980936 Free PMC article.
References
-
- Kirksey MA, Yang EI, Kuvadia M, Miller AO (2020) Management considerations for the COVID-19 patient with severe disease: a case scenario and literature review. HSS J 16(Suppl 1):153–159. https://doi.org/10.1007/s11420-020-09789-x - DOI - PubMed - PMC
-
- Statement on the thirteenth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic (2022). World Health Organization, World Health Organization
-
- Hall AJ, Clement ND, Group IR, MacLullich AMJ, White TO, Duckworth AD (2022) COVID-19 during the index hospital admission confers a “double-hit” effect on hip fracture patients and is associated with a two-fold increase in 1-year mortality risk. Musculoskeletal Care 20(3):705–717. https://doi.org/10.1002/msc.1674 - DOI - PubMed - PMC
-
- Puzzitiello RN, Pagani NR, Moverman MA, Moon AS, Menendez ME, Ryan SP (2020) Inflammatory and coagulative considerations for the management of orthopaedic trauma patients with COVID-19: a review of the current evidence and our surgical experience. J Orthop Trauma 34(8):389–394. https://doi.org/10.1097/BOT.0000000000001842 - DOI - PubMed
-
- Pectol RW, Kavolus MW, Sneed CR, Albano AY, Landy DC, Aneja A, the C-Org (2022) Outcomes of reamed intramedullary nailing for lower extremity diaphyseal fractures in COVID-positive patients: a multi-institutional observational study. J Orthop Trauma 36(12):628–633. https://doi.org/10.1097/BOT.0000000000002468 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous